Categories: The Commercial Chemist | No Comments
Lilly goes for diabetes in China
US pharma company Eli Lilly is planning to open a research centre in Shanghai, China, that will focus on new medicines for the treatment of diabetes.
‘We are establishing this research centre, first and foremost, to meet the growing unmet medical needs of those living in China with diabetes,’ said Jan Lundberg, executive vice president, science and technology. The company says that diabetes is a growing problem in China due to longer life expectancy, dietary changes and lack of exercise.
The new centre will employ 100 scientists and support staff, mostly hired from within China. Lilly says that, since the late 1990s, it has invested more than ¥2 billion (£190 million) in the country. (more…)